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It’s well established that asthma, allergic rhinitis and rhinosinusitis are three closely related disease. In pediatrics,
these conditions represent a common issue in daily practice. The scientific community has recently started to
simply evaluate them as different manifestations of a common pathogenic phenomenon. This consideration relates
to important implications in the clinical management of these diseases, which may affect the daily activity of a
pediatrician. The unity of the respiratory tract is confirmed both from a morphological and from a functional point
of view. When treating rhinitis, it is often necessary to assess the presence of asthma. Patients with sinusitis should
be evaluated for a possible concomitant asthma. Conversely, patients with asthma should always be evaluated for
possible nasal disease, especially those suffering from difficult-to-treat asthma, in which an occult sinusitis may be
detected. The medications that treat nasal diseases appear to be useful in improving asthma control and in
reducing bronchial hyperresponsiveness. It seems therefore important to analyze the link between asthma and
sinusitis, both in terms of clinical and pathogenic features, as well the therapeutic approach of those patients
presenting with these diseases.
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The link between asthma, allergic rhinitis and rhinosinu-
sitis is well known and internationally accepted, while
the precise concept of an united airways disease has
been postulated only recently [1]. The atopic diseases of
the nose and the lungs are, in fact, related to each other,
and coexist in many patients, with a much higher
frequency than expected, when simply considering the
prevalence of each disease in the general population [2].
The immediate sign that the airways diseases coexist is
given by the fact that upper respiratory tract infections
are capable of exacerbating asthma, while rhinosinusitis
has been identified as an independent risk factor for
asthma development [3,4]. Even though this connection
seems clear from a theoretical point of view, in daily
practice, children presenting with nasal and respiratory
symptoms are generally treated by two different
specialists.
In Italy, the prevalence of current asthma, allergic
rhinoconjunctivitis, and atopic eczema in 2006 was
7.9%, 6.5%, and 10.1% among children aged 6–7 and
8.4%, 15.5%, and 7.75% among children aged 13–14* Correspondence: davide.caimmi@gmail.com
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reproduction in any medium, provided the oryears [5]. In children, atopic dermatitis represents the
first step of the atopic march, followed by allergic
rhinitis and asthma. We should start thinking now that
the atopic march consists of a two-steps march, that is
to say that eczema is the initial symptom of a change
in the child’s immune system, followed by atopic
respiratory symptoms, involving the nose, the nasal
sinuses and the lungs [6]. The upper and lower
respiratory tracts form a continuum and share many
anatomical and histological properties and an import-
ant feature: the passage of air into and out of the
lungs. Anatomically, the respiratory tree is classically
distinguished into nose, mouth, pharynx, larynx,
trachea and bronchi, which, in turn, are dicotomically
divided until the respiratory bronchioles. These lasts,
with their air cells, correspond to the respiratory
portion reserved for pulmonary gas exchange. The
upper respiratory tract begins with the nostrils and the
mouth and ends with the larynx, while the lower tract
goes from the larynx to the alveoli.Common triggers: not only allergy
The natural progression of respiratory allergy commonly
starts from the upper respiratory tract and later spreads
to the lower tract [7].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Viruses and bacteria are responsible for infectious rhin-
itis, rhinosinusitis, bronchiolitis and pneumonia. In chil-
dren, viruses are known to cause asthma exacerbation as
well. Cigarette smoke and pollutants, atmospheric or
professional, may damage the epithelium as well, and
they may be responsible for a chronic inflammation.
Tobacco smoke exposure in children is responsible of
airways inflammation and infections, involving both the
upper and the lower respiratory tract [8]. At last, even
though asthma and allergic rhinitis are hypersensitivity
reactions, they may also be triggered by drugs such as
beta-blockers or aspirin, cold dry air exposure, and phys-
ical exercise [9].
It is clear, though, that allergens are potent stimuli of
allergic rhinitis and asthma. Allergic patients suffer from
a general inflammatory status interesting the whole
respiratory tract and manifesting through different
diseases, affecting the nose, the paranasal sinuses and
the bronchi [10]. Nasal allergen exposure, in patients
suffering from allergic rhinitis, may rapidly lead to a
significant pulmonary allergic inflammation, even in
subjects without a history of bronchial hyperreactivity
[11]. Moreover, segmental bronchial challenge may
induce nasal symptoms and inflammation in patients
suffering from allergic rhinitis, as nasal challenge may
induce a decline in respiratory functions [12,13]. The
rates of indoor allergens such as dust mites or animal
proteins are highly correlated with asthma, while the
rates of outdoor allergens such as pollen are more often
associated with rhinitis [14].
A common pathogenesis
Several studies in recent years have tried to clarify what
is beneath the link between inflammation of the upper
and lower respiratory tract. Main theories include the
nasal-bronchial reflex, the presence of inflammatory
mediators draining from the upper to the lower respira-
tory tract, the role played by environmental factors, and
the presence of a certain degree of hyperreactivity, inter-
esting the epithelium of the entire respiratory tract [15].
In patients with asthma, the characteristics of the
inflammation of the upper respiratory tract has com-
mon features with inflammation in the lung, such as
the increased production of IgEs and the important
role played by eosinophils, and cytokines (such as
Interleukin-5) [16].
Various studies in recent years try to define and clarify
the degree of inflammation in the lower respiratory tract
in healthy patients, in patients with rhinitis, and in sub-
jects with asthma and rhinosinusitis. The results of the
various studies, however, have confirmed that the con-
centration of certain mediators (such as exhaled nitric
oxide, or the amount of eosinophilic cationic protein,Inerleukin-5 and VEGF on sputum) show incremental
values from healthy controls to patients with asthma
and rhinitis and/or rhinosinusitis [17-21]. All these find-
ings have been able to corroborate the theory of the
“united airways disease”, considering therefore the upper
and lower airways as a single anatomo-functional and
pathogenic entity [15].
The link between allergic rhinitis and asthma
Allergic rhinitis is the most common of all atopic dis-
eases and it may develop at any age, even though in
those patients who present during the first years of life
signs of atopic dermatitis, it usually appears before the
school age. Allergic rhinitis may be intermittent or per-
sistent, depending on how long the symptoms last, and
mild or moderate/severe, on the basis of the severity of
the symptoms experienced by the patient [22]. Besides
the classical symptoms of sneezing, rhinorrhea, and
nasal obstruction, AR is characterized by impairment in
the patients’ quality of life, and potentially by sleep dis-
orders, emotional problems, impairment in activities,
and social functioning [22,23].
Asthma is defined as a disease of reversible airway ob-
struction and is diagnosed by using measures of lung
function and bronchial hyperreactivity. Main symptoms
include dry cough, expiratory wheezing, chest tightness
and dyspnoea, which are intermittently triggered by
allergens, infections and airways irritants [24]. Small air-
way disease, defined as a reduction in forced expiratory
flow (FEF) at 25–75% of the pulmonary volume and a
normal spirometry, is suggested to be a marker of early
allergic or inflammatory involvement of the small air-
ways in subjects with allergic diseases and no asthma
[25]. FEF25–75 seems to be significantly associated with
bronchial hyperreactivity, and it has been proposed as
an early marker of bronchial involvement in patients
with allergic rhinitis who perceive nasal symptoms only
[26,27]. In general, and this is especially true in children,
there are even serum markers (such as Interleukin-23)
able to highlight the severity of the respiratory disease,
and the initial involvement of the small airways that
characterizes the bronchial hyperresponsiveness [28,29].
Allergic rhinitis is considered as a risk factor for devel-
oping asthma, but it is possible that this term is not to-
tally correct in the sense that this condition may
represent an early stage of the united airways disease
that may progress to asthma [25]. Approximately 19–
38% of patients with allergic rhinitis have concomitant
asthma and 30–80% of asthmatics have allergic rhinitis,
although these data probably underestimate the
phenomenon, as recent surveys found symptoms of
rhinitis in 98.9% of allergic asthmatics and in 78.4% of
non-allergic asthmatics [30]. Moreover, most of patients
with allergic rhinitis show bronchial hyperreactivity,
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function impairment nor of asthma and such a finding
may represent a prognostic factor for further progression
to asthma [31].
In those patients presenting with both allergic rhinitis
and asthma at the same time, a significantly higher num-
ber of aeroallergen sensitizations may be detected than
in those without asthma, and patients suffering from
perennial rhinitis present an increased risk to develop
asthma [32].
A small proportion of asthmatic patients present a se-
vere form of asthma, which often requires a continuous
and long-term treatment with oral corticosteroids to
control symptoms [33]. Since difficult asthma is rare in
childhood, when asthma is difficult to treat and poorly
controlled, a special evaluation should include the re-
view of diagnosis with accurate lung function and the
evaluation of possible comorbidities.
The link between rhinosinusitis and asthma
The term rhinosinusitis refers to the presence of inflam-
mation within any of the four pairs of paranasal sinuses.
Symptoms include nasal congestion, nasal discharge,
nasal purulence, postnasal drip, facial pressure, hypos-
mia, cough, fever, halitosis, dental pain, ear fullness, and
headache. The pathogenesis of this disease is poorly
understood. The long-term consequences of chronic si-
nusitis may include lose of mucociliary clearance and of
other physiologic mechanisms that normally maintain
the relative sterility of the sinuses [34].
In children, paranasal sinuses disease is considered to
an important risk factor for the development of lower
respiratory tract diseases, and rhinosinusitis and asthma
seem to be two different expressions of a common
pathological process [33]. Recent progress in under-
standing the biology of airway disease has identified in-
flammation as the key to understand these diseases.
Nevertheless, several other mechanisms that link the
upper (nose, sinuses, larynx, pharynx, and trachea) and
lower (bronchi and lungs) airway segments may be
involved too [35].
Precipitants of asthma are generally also precipitants
of sinusitis, and, therefore, the association of sinusitis
with asthma exacerbations may be an epiphenomenon
[34]. Rhinosinusitis coexists with asthma in 34–50% of
patients [36]. Nevertheless, in patients presenting with
asthma, the incidence of concomitant rhinosinusitis rise
up to 84%, especially during asthma exacerbations [36].
The observation that asthma and rhinosinusitis coexist
in patients at a higher frequency than would be expected
from the prevalence of each in the general population
provides a strong connection between the upper and
lower airways [37]. Sinonasal disease in asthmatics
appears to differ somewhat from that of the generalpopulation and the temporal sequence of disease and
parallel inflammatory pathways involved suggest that
they may be progressive manifestations of a common
disease process [38]. It should also be pointed out that
the characteristics of patients with chronic allergic rhi-
nosinusitis differ from those of patients with non-
allergic rhinosinusitis: in fact, the first group of patients
are more frequently affected by asthma, and have a
higher risk of having nasal polyposis, if compared to the
second group [39].
Therapeutic implications
There are several studies that have investigated whether
improved control of sinusitis in a child with asthma also
means improving asthma symptoms. Although further
studies are certainly need to reach a definitive conclu-
sion, different results seem to now provide encouraging
data in this regard [40-42]. It was for example shown
that patients with severe asthma are frequently bearers
of the worst sinusal lesions, and that medical treatment
of rhinosinusitis results in an improvement of clinical
asthma and in a greater control of respiratory symptoms.
Moreover, many papers have focused on the fact that an
early allergen immunotherapy may not only reduce
asthma symptoms but also improve the nasal disease as
well [43,44].
The natural consequence of these considerations is that
occult sinusitis may stand beneath many asthma exacerba-
tions. Occult sinusitis is a clinically unrecognized sinusitis,
which can be highlighted through imaging and is asso-
ciated with a worse respiratory involvement. It is therefore
important to exclude the presence of a sinusitis in patients
with frequent exacerbations of asthma. Finally, it also
seems reasonable to ask whether a prompt and early treat-
ment of sinus infections in a patient with atopic eczema
may affect the subsequent development of asthma: how-
ever, such a hypothesis, although some studies leave some
hope, is not easy to demonstrate.
Another important issue that requires patients suffer-
ing from airways allergic disease to be properly treated,
with a complete control of their respiratory symptoms,
is the possibility of a surgical intervention. In fact, asth-
matic patients or patients suffering from important nasal
symptoms are often more at risk than the general popu-
lation of developing complications during surgery, if
their disease is not completely controlled. This implica-
tion seems even more important if we consider that sur-
gical stress induces complex modifications in the
hemodynamic, metabolic, neuro-hormonal and immune
response of the individual, leading therefore to an
increased risk not only of respiratory reactions, but also
of infectious septic complications [45-47].
In conclusion, the therapeutic approach should focus
not only on the control of the united airways disease to
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better quality of life in patients and to let them be com-
parable to the general population in everyday settings.Conclusions
Asthma, rhinitis, and sinusitis are three conditions fre-
quently encountered during childhood, they have a com-
mon pathophysiological origin, and they may be
associated to environmental stimuli and immunological
predisposition [48]. Although further studies are cer-
tainly needed to clarify many aspects of this close rela-
tionship, pediatricians have to take into account, in
approaching an asthmatic child, the possible nasal in-
volvement, that we could call the “nasal asthma”. In clin-
ical practice, therefore, a rigorous treatment of comorbid
factors of ashtma, such as rhinosinusitis, could result in
less asthma exacerbations, which will greatly improve
the quality of life of difficult-to-control asthmatic
patients. In conclusion, treating asthma means also
treating the nose, while treating patients with nasal
symptoms has to be associated to a proper lung function
evaluation, since the nose and the lungs should always
be considered as a unique entity.
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